Biotech Archives - Page 48 of 795

2 minute read

bioAffinity Technologies News Update, CyPath Lung Sales Ramp Up Month Over Month

May 2, 8:15 AM

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW))) shares recent Company news.CyPath® Lung Sales Ramp Up Month over MonthSales of CyPath® Lung, our noninvasive diagnostic test for the early detection of lung

BIAF

3 minute read

FDA
News

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy Designation Granted By U.S. FDA For TSHA-102 In Rett Syndrome

By Benzinga Newsdesk

May 2, 8:10 AM

RMAT designation follows FDA's review of available safety and efficacy data from the first three patients dosed with the low dose of TSHA-102 across both REVEAL Phase 1/2 trials (adolescent/adult and pediatric) RMAT

TSHA

1 minute read

Daré Bioscience Selected As A Member Of ARPA-H Investor Catalyst Hub Spoke Network

By Benzinga Newsdesk

May 2, 8:10 AM

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network

DARE

3 minute read

LifeMD Becomes The First Virtual Primary Care Provider To Elevate GLP-1 Patient Care With Real-time, At-Home Monitoring Of Blood Pressure And Body Composition

By Benzinga Newsdesk

May 2, 8:09 AM

LifeMD, Inc.® (NASDAQ:LFMD), a leading provider of virtual primary care services, and Withings Health Solutions, a leader in digital health technology, announce a new strategic partnership designed to

LFMD

3 minute read

Allurion Announces Three Scientific Presentations At IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey

By Benzinga Newsdesk

May 2, 8:08 AM

New data demonstrates 80% sustained weight loss at three years with the Allurion Program and initial positive outcomes of a novel, generative AI-powered conversational agent for obesity treatmentAllurion Technologies,

ALUR

3 minute read

Initial Clinical Data Reported From Immutep’s Efti Combined With Radiotherapy And Checkpoint Inhibitor From Phase II Trial In Soft Tissue Sarcoma

By Benzinga Newsdesk

May 2, 8:07 AM

Novel triple combination of efti with radiotherapy and anti-PD-1 therapy is well tolerated and has led to encouraging initial efficacy data in EFTISARC-NEO Phase II trialFour of six patients treated have very good,

IMMP

4 minute read

Lucid Diagnostics Announces Peer-Reviewed Publication Of Data From National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study Of EsoGuard Esophageal Precancer Testing

By Benzinga Newsdesk

May 2, 7:54 AM

EsoGuard demonstrated unprecedented early precancer detection, including 89% sensitivity at detecting short segment early precancer, the primary target of esophageal precancer testingPublication further strengthens

LUCD

2 minute read

Federal Trade Commission Targets ‘Junk Patent Listings’ For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca

By Vandana Singh

May 1, 4:11 PM

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, and COPD medications. This initiative combats tactics hindering generic competition.

AMPH